Literature DB >> 13585142

Plasmanate: a new plasma substitute for pediatric therapy.

T C COCK, C M BINGER, J L DENNIS.   

Abstract

Plasmanate(R), a human-serum protein solution, appears to have all the attributes of an ideal plasma expander. Freedom from infection, immediate availability in a clear, stable solution and the apparent absence of antigenic properties are particularly valuable qualities. The efficacy and safety of Plasmanate was clinically demonstrated in the treatment of 125 infants and children. This solution seems especially effective in the treatment of acute shock states and for the physiologic correction of hypoproteinemia. Comparison with other plasma expanders makes Plasmanate the agent of choice in the initial treatment of shock states in pediatrics.

Entities:  

Keywords:  BLOOD PROTEINS/deficiency; PLASMA SUBSTITUTES/therapeutic use; SHOCK/in infant and child

Mesh:

Substances:

Year:  1958        PMID: 13585142      PMCID: PMC1512348     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  8 in total

1.  Preparation and properties of a heat-treated human plasma protein fraction.

Authors:  J H HINK; J HIDALGO; V P SEEBERG; F F JOHNSON
Journal:  Vox Sang       Date:  1957-07       Impact factor: 2.144

2.  Dextran and prolonged bleeding time; results of a sixty-gram, one-liter infusion given to one hundred sixty-three normal human subjects.

Authors:  R D LANGDELL; E ADELSON; F W FURTH; W H CROSBY
Journal:  J Am Med Assoc       Date:  1958-01-25

3.  Changes in total chloride and acid-base balance in gastroenteritis following treatment with large and small loads of sodium chloride.

Authors:  D B CHEEK
Journal:  Pediatrics       Date:  1956-06       Impact factor: 7.124

4.  Pooled plasma with little or no risk of homologous serum jaundice.

Authors:  J G ALLEN; D M ENERSON; E S BARRON
Journal:  J Am Med Assoc       Date:  1954-01-09

5.  The present status of plasma expanders.

Authors:  F W HARTMAN; V G BEHRMANN
Journal:  J Am Med Assoc       Date:  1953-07-18

6.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT.

Authors:  S S Gellis; J R Neefe; J Stokes; L E Strong; C A Janeway; G Scatchard
Journal:  J Clin Invest       Date:  1948-03       Impact factor: 14.808

7.  Plasma expanders.

Authors:  I S RAVDIN
Journal:  J Am Med Assoc       Date:  1952-09-06

8.  Studies on the generalized Shwartzman reaction. VI. Production of the reaction by the synergistic action of endotoxin with three synthetic acidic polymers (sodium polyanethod sulfonate, dextran sulfate, and sodium polyvinyl alcohol sulfonate).

Authors:  L THOMAS; J BRUNSON; R T SMITH
Journal:  J Exp Med       Date:  1955-09-01       Impact factor: 14.307

  8 in total
  1 in total

1.  Newer concepts in the management of tetanus.

Authors:  T C COCK
Journal:  Calif Med       Date:  1961-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.